Report
Fastest Growing Biotech Companies & Startups (2024)
Feb 7, 2024
Published by
Specter
Report
Fastest Growing Biotech Companies & Startups (2024)
Feb 7, 2024
Published by
Specter
Report
Fastest Growing Biotech Companies & Startups (2024)
Feb 7, 2024
Published by
Specter
Report
Fastest Growing Biotech Companies & Startups (2024)
Feb 7, 2024
Published by
Specter
The biotech industry is undergoing an extraordinary transformation, changing the way we approach health and science. In 2023, the global biotechnology market was valued at a staggering $1.55 trillion, and it's not slowing down. With projections showing a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, it's clear this field is not just growing; it's booming. This growth is fuelled by groundbreaking developments, from new disease treatments to advancements in DNA technology, marking a significant leap from the field's early days. What was once the realm of science fiction is now a reality, improving with each day and bringing solutions to major global issues like health, food security, and environmental challenges.
This thriving sector is a mix of veteran companies with deep roots and emerging startups bursting with innovative ideas. The established players have paved the way with their extensive research and development, while the new entrants are bringing fresh perspectives and disruptive technologies. This dynamic blend is driving the biotech industry forward, making it an exciting field to watch. The financial outlook is just as impressive as the scientific achievements. The industry's robust market value and its projected growth signify not only its economic strength but also its increasing importance in developing new technologies and enhancing global health in the coming years.
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
After crunching the numbers, here are 10 of the fastest growing biotech companies:
Beta Bionics is swiftly carving out its niche in the biotech sector as the creator of the iLet Bionic Pancreas System, a game-changing technology in diabetes management. This Massachusetts-based innovator has recently accelerated its growth by securing FDA clearance and attracting $100 million in series D funding, highlighting its potential and commitment to revolutionise care for diabetes patients.
Founded Date:
2015
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
38%
Web Visits Growth (Last 6 months):
250%
Seismic Therapeutic is reshaping immunology drug development by harnessing machine learning to speed up the creation of new treatments for autoimmune diseases. Their cutting-edge IMPACT™ platform integrates technology with biology, leading to more efficient therapy discovery. With a recent boost of $121 million in Series B funding from top investors, including Bessemer Venture Partners, Seismic is poised to advance its leading drug candidates, S-1117 and S-4321, into early clinical trials.
Founded Date:
2020
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
8.5%
Web Visits Growth (Last 6 months):
158%
Watchmaker Genomics, nestled in Boulder, Colorado, is transforming health care with its groundbreaking DNA technology aimed at early disease detection. Their innovative approach to analysing DNA changes has the potential to significantly improve how we identify diseases like cancer. This pioneering effort in medical diagnostics is making advanced health solutions more accessible and could change the future of health care.
Founded Date:
2019
HQ Location:
Colorado, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
9.6%
Web Visits Growth (Last 6 months):
53%
ZBiotics, based in San Francisco, is at the forefront of synthetic biology, creating genetically engineered probiotics to enhance health in innovative ways. Founded by scientists, the company's first product effectively tackles alcohol byproducts in the gut, leading a new wave of solutions for modern health challenges. ZBiotics stands out for its focus on using genetic engineering to improve bodily functions, reflecting a growing consumer trend towards proactive health and wellness management.
Founded Date:
2016
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
69%
Aptitude Medical Systems is on a mission to make health testing simple and accessible for everyone, everywhere. With backing from the Bill & Melinda Gates Foundation, they're pioneering easy-to-use diagnostic tests that can quickly identify health conditions, including STIs, right at home or in clinics. Their work, which builds on their success with an easy COVID-19 home test, aims to break down barriers to healthcare, especially in underserved areas.
Founded Date:
2011
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
31%
Web Visits Growth (Last 6 months):
301%
Loam Bio, founded in 2019 in New South Wales, is changing farming for the better by using special microbes to help crops grow stronger and healthier, while also helping the planet by storing more carbon in the soil. This innovative approach not only makes the soil better for future planting but also fights climate change.
Founded Date:
2019
HQ Location:
New South Wales, Australia
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
47%
Web Visits Growth (Last 6 months):
194%
Aspect Biosystems is revolutionising regenerative medicine with its innovative bioprinted tissue therapeutics, targeting challenging conditions like diabetes and obesity. By blending microfluidic 3D bioprinting technology with therapeutic cells, this Vancouver-based biotech company is creating treatments capable of repairing or replacing damaged organs.
Founded Date:
2013
HQ Location:
British Columbia, Canada
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
97%
Kriya Therapeutics, a California-based biotech innovator, is at the forefront of gene therapy, focusing on transformative treatments for metabolic, neurological, and eye diseases. Last year, the company significantly advanced its mission by securing over $430 million in Series C funding, contributing to a total of $600 million raised since its inception in 2019.
Founded Date:
2019
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
1.1%
Web Visits Growth (Last 6 months):
218%
Generate Biomedicines, a trailblazer in Generative Biology, is transforming drug discovery with its machine learning-driven approach to designing and optimising protein-based medicines. Founded in 2018, the company has quickly risen to prominence, securing a groundbreaking $273 million in Series C funding last year, bringing its total financing to nearly $700 million.
Founded Date:
2018
HQ Location:
Pennsylvania, United States
Total Funding Raised:
$
Company Size:
(
201-500
)
Employee Growth (Last 6 months):
7%
Web Visits Growth (Last 6 months):
145%
Zymvol, based in Barcelona, is transforming the development of industrial enzymes through computer simulations. This innovative approach speeds up the creation of enzymes for use in pharmaceuticals, chemicals, and food industries, bypassing traditional lab methods for more efficient outcomes. Zymvol's cutting-edge technology is setting new standards in biotechnology, making significant strides globally.
Founded Date:
2017
HQ Location:
Catalonia, Spain
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
19%
Web Visits Growth (Last 6 months):
70%
The biotech industry is undergoing an extraordinary transformation, changing the way we approach health and science. In 2023, the global biotechnology market was valued at a staggering $1.55 trillion, and it's not slowing down. With projections showing a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, it's clear this field is not just growing; it's booming. This growth is fuelled by groundbreaking developments, from new disease treatments to advancements in DNA technology, marking a significant leap from the field's early days. What was once the realm of science fiction is now a reality, improving with each day and bringing solutions to major global issues like health, food security, and environmental challenges.
This thriving sector is a mix of veteran companies with deep roots and emerging startups bursting with innovative ideas. The established players have paved the way with their extensive research and development, while the new entrants are bringing fresh perspectives and disruptive technologies. This dynamic blend is driving the biotech industry forward, making it an exciting field to watch. The financial outlook is just as impressive as the scientific achievements. The industry's robust market value and its projected growth signify not only its economic strength but also its increasing importance in developing new technologies and enhancing global health in the coming years.
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
After crunching the numbers, here are 10 of the fastest growing biotech companies:
Beta Bionics is swiftly carving out its niche in the biotech sector as the creator of the iLet Bionic Pancreas System, a game-changing technology in diabetes management. This Massachusetts-based innovator has recently accelerated its growth by securing FDA clearance and attracting $100 million in series D funding, highlighting its potential and commitment to revolutionise care for diabetes patients.
Founded Date:
2015
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
38%
Web Visits Growth (Last 6 months):
250%
Seismic Therapeutic is reshaping immunology drug development by harnessing machine learning to speed up the creation of new treatments for autoimmune diseases. Their cutting-edge IMPACT™ platform integrates technology with biology, leading to more efficient therapy discovery. With a recent boost of $121 million in Series B funding from top investors, including Bessemer Venture Partners, Seismic is poised to advance its leading drug candidates, S-1117 and S-4321, into early clinical trials.
Founded Date:
2020
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
8.5%
Web Visits Growth (Last 6 months):
158%
Watchmaker Genomics, nestled in Boulder, Colorado, is transforming health care with its groundbreaking DNA technology aimed at early disease detection. Their innovative approach to analysing DNA changes has the potential to significantly improve how we identify diseases like cancer. This pioneering effort in medical diagnostics is making advanced health solutions more accessible and could change the future of health care.
Founded Date:
2019
HQ Location:
Colorado, United States
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
9.6%
Web Visits Growth (Last 6 months):
53%
ZBiotics, based in San Francisco, is at the forefront of synthetic biology, creating genetically engineered probiotics to enhance health in innovative ways. Founded by scientists, the company's first product effectively tackles alcohol byproducts in the gut, leading a new wave of solutions for modern health challenges. ZBiotics stands out for its focus on using genetic engineering to improve bodily functions, reflecting a growing consumer trend towards proactive health and wellness management.
Founded Date:
2016
HQ Location:
California, United States
Total Funding Raised:
$
Employ
(
11-50
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
69%
Aptitude Medical Systems is on a mission to make health testing simple and accessible for everyone, everywhere. With backing from the Bill & Melinda Gates Foundation, they're pioneering easy-to-use diagnostic tests that can quickly identify health conditions, including STIs, right at home or in clinics. Their work, which builds on their success with an easy COVID-19 home test, aims to break down barriers to healthcare, especially in underserved areas.
Founded Date:
2011
HQ Location:
California, United States
Total Funding Raised:
$
Employ
(
11-50
)
Employee Growth (Last 6 months):
31%
Web Visits Growth (Last 6 months):
301%
Loam Bio, founded in 2019 in New South Wales, is changing farming for the better by using special microbes to help crops grow stronger and healthier, while also helping the planet by storing more carbon in the soil. This innovative approach not only makes the soil better for future planting but also fights climate change.
Founded Date:
2019
HQ Location:
New South Wales, Australia
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
47%
Web Visits Growth (Last 6 months):
194%
Aspect Biosystems is revolutionising regenerative medicine with its innovative bioprinted tissue therapeutics, targeting challenging conditions like diabetes and obesity. By blending microfluidic 3D bioprinting technology with therapeutic cells, this Vancouver-based biotech company is creating treatments capable of repairing or replacing damaged organs.
Founded Date:
2013
HQ Location:
British Columbia, Canada
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
97%
Kriya Therapeutics, a California-based biotech innovator, is at the forefront of gene therapy, focusing on transformative treatments for metabolic, neurological, and eye diseases. Last year, the company significantly advanced its mission by securing over $430 million in Series C funding, contributing to a total of $600 million raised since its inception in 2019.
Founded Date:
2019
HQ Location:
California, United States
Total Funding Raised:
$
Employ
(
51-200
)
Employee Growth (Last 6 months):
1.1%
Web Visits Growth (Last 6 months):
218%
Generate Biomedicines, a trailblazer in Generative Biology, is transforming drug discovery with its machine learning-driven approach to designing and optimising protein-based medicines. Founded in 2018, the company has quickly risen to prominence, securing a groundbreaking $273 million in Series C funding last year, bringing its total financing to nearly $700 million.
Founded Date:
2018
HQ Location:
Pennsylvania, United States
Total Funding Raised:
$
Employ
(
201-500
)
Employee Growth (Last 6 months):
7%
Web Visits Growth (Last 6 months):
145%
Zymvol, based in Barcelona, is transforming the development of industrial enzymes through computer simulations. This innovative approach speeds up the creation of enzymes for use in pharmaceuticals, chemicals, and food industries, bypassing traditional lab methods for more efficient outcomes. Zymvol's cutting-edge technology is setting new standards in biotechnology, making significant strides globally.
Founded Date:
2017
HQ Location:
Catalonia, Spain
Total Funding Raised:
$
Employ
(
11-50
)
Employee Growth (Last 6 months):
19%
Web Visits Growth (Last 6 months):
70%
The biotech industry is undergoing an extraordinary transformation, changing the way we approach health and science. In 2023, the global biotechnology market was valued at a staggering $1.55 trillion, and it's not slowing down. With projections showing a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, it's clear this field is not just growing; it's booming. This growth is fuelled by groundbreaking developments, from new disease treatments to advancements in DNA technology, marking a significant leap from the field's early days. What was once the realm of science fiction is now a reality, improving with each day and bringing solutions to major global issues like health, food security, and environmental challenges.
This thriving sector is a mix of veteran companies with deep roots and emerging startups bursting with innovative ideas. The established players have paved the way with their extensive research and development, while the new entrants are bringing fresh perspectives and disruptive technologies. This dynamic blend is driving the biotech industry forward, making it an exciting field to watch. The financial outlook is just as impressive as the scientific achievements. The industry's robust market value and its projected growth signify not only its economic strength but also its increasing importance in developing new technologies and enhancing global health in the coming years.
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
After crunching the numbers, here are 10 of the fastest growing biotech companies:
Beta Bionics is swiftly carving out its niche in the biotech sector as the creator of the iLet Bionic Pancreas System, a game-changing technology in diabetes management. This Massachusetts-based innovator has recently accelerated its growth by securing FDA clearance and attracting $100 million in series D funding, highlighting its potential and commitment to revolutionise care for diabetes patients.
Founded Date:
2015
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
38%
Web Visits Growth (Last 6 months):
250%
Seismic Therapeutic is reshaping immunology drug development by harnessing machine learning to speed up the creation of new treatments for autoimmune diseases. Their cutting-edge IMPACT™ platform integrates technology with biology, leading to more efficient therapy discovery. With a recent boost of $121 million in Series B funding from top investors, including Bessemer Venture Partners, Seismic is poised to advance its leading drug candidates, S-1117 and S-4321, into early clinical trials.
Founded Date:
2020
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
8.5%
Web Visits Growth (Last 6 months):
158%
Watchmaker Genomics, nestled in Boulder, Colorado, is transforming health care with its groundbreaking DNA technology aimed at early disease detection. Their innovative approach to analysing DNA changes has the potential to significantly improve how we identify diseases like cancer. This pioneering effort in medical diagnostics is making advanced health solutions more accessible and could change the future of health care.
Founded Date:
2019
HQ Location:
Colorado, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
9.6%
Web Visits Growth (Last 6 months):
53%
ZBiotics, based in San Francisco, is at the forefront of synthetic biology, creating genetically engineered probiotics to enhance health in innovative ways. Founded by scientists, the company's first product effectively tackles alcohol byproducts in the gut, leading a new wave of solutions for modern health challenges. ZBiotics stands out for its focus on using genetic engineering to improve bodily functions, reflecting a growing consumer trend towards proactive health and wellness management.
Founded Date:
2016
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
69%
Aptitude Medical Systems is on a mission to make health testing simple and accessible for everyone, everywhere. With backing from the Bill & Melinda Gates Foundation, they're pioneering easy-to-use diagnostic tests that can quickly identify health conditions, including STIs, right at home or in clinics. Their work, which builds on their success with an easy COVID-19 home test, aims to break down barriers to healthcare, especially in underserved areas.
Founded Date:
2011
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
31%
Web Visits Growth (Last 6 months):
301%
Loam Bio, founded in 2019 in New South Wales, is changing farming for the better by using special microbes to help crops grow stronger and healthier, while also helping the planet by storing more carbon in the soil. This innovative approach not only makes the soil better for future planting but also fights climate change.
Founded Date:
2019
HQ Location:
New South Wales, Australia
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
47%
Web Visits Growth (Last 6 months):
194%
Aspect Biosystems is revolutionising regenerative medicine with its innovative bioprinted tissue therapeutics, targeting challenging conditions like diabetes and obesity. By blending microfluidic 3D bioprinting technology with therapeutic cells, this Vancouver-based biotech company is creating treatments capable of repairing or replacing damaged organs.
Founded Date:
2013
HQ Location:
British Columbia, Canada
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
97%
Kriya Therapeutics, a California-based biotech innovator, is at the forefront of gene therapy, focusing on transformative treatments for metabolic, neurological, and eye diseases. Last year, the company significantly advanced its mission by securing over $430 million in Series C funding, contributing to a total of $600 million raised since its inception in 2019.
Founded Date:
2019
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
1.1%
Web Visits Growth (Last 6 months):
218%
Generate Biomedicines, a trailblazer in Generative Biology, is transforming drug discovery with its machine learning-driven approach to designing and optimising protein-based medicines. Founded in 2018, the company has quickly risen to prominence, securing a groundbreaking $273 million in Series C funding last year, bringing its total financing to nearly $700 million.
Founded Date:
2018
HQ Location:
Pennsylvania, United States
Total Funding Raised:
$
Company Size:
(
201-500
)
Employee Growth (Last 6 months):
7%
Web Visits Growth (Last 6 months):
145%
Zymvol, based in Barcelona, is transforming the development of industrial enzymes through computer simulations. This innovative approach speeds up the creation of enzymes for use in pharmaceuticals, chemicals, and food industries, bypassing traditional lab methods for more efficient outcomes. Zymvol's cutting-edge technology is setting new standards in biotechnology, making significant strides globally.
Founded Date:
2017
HQ Location:
Catalonia, Spain
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
19%
Web Visits Growth (Last 6 months):
70%
The biotech industry is undergoing an extraordinary transformation, changing the way we approach health and science. In 2023, the global biotechnology market was valued at a staggering $1.55 trillion, and it's not slowing down. With projections showing a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, it's clear this field is not just growing; it's booming. This growth is fuelled by groundbreaking developments, from new disease treatments to advancements in DNA technology, marking a significant leap from the field's early days. What was once the realm of science fiction is now a reality, improving with each day and bringing solutions to major global issues like health, food security, and environmental challenges.
This thriving sector is a mix of veteran companies with deep roots and emerging startups bursting with innovative ideas. The established players have paved the way with their extensive research and development, while the new entrants are bringing fresh perspectives and disruptive technologies. This dynamic blend is driving the biotech industry forward, making it an exciting field to watch. The financial outlook is just as impressive as the scientific achievements. The industry's robust market value and its projected growth signify not only its economic strength but also its increasing importance in developing new technologies and enhancing global health in the coming years.
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
After crunching the numbers, here are 10 of the fastest growing biotech companies:
Beta Bionics is swiftly carving out its niche in the biotech sector as the creator of the iLet Bionic Pancreas System, a game-changing technology in diabetes management. This Massachusetts-based innovator has recently accelerated its growth by securing FDA clearance and attracting $100 million in series D funding, highlighting its potential and commitment to revolutionise care for diabetes patients.
Founded Date:
2015
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
38%
Web Visits Growth (Last 6 months):
250%
Seismic Therapeutic is reshaping immunology drug development by harnessing machine learning to speed up the creation of new treatments for autoimmune diseases. Their cutting-edge IMPACT™ platform integrates technology with biology, leading to more efficient therapy discovery. With a recent boost of $121 million in Series B funding from top investors, including Bessemer Venture Partners, Seismic is poised to advance its leading drug candidates, S-1117 and S-4321, into early clinical trials.
Founded Date:
2020
HQ Location:
Massachusetts, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
8.5%
Web Visits Growth (Last 6 months):
158%
Watchmaker Genomics, nestled in Boulder, Colorado, is transforming health care with its groundbreaking DNA technology aimed at early disease detection. Their innovative approach to analysing DNA changes has the potential to significantly improve how we identify diseases like cancer. This pioneering effort in medical diagnostics is making advanced health solutions more accessible and could change the future of health care.
Founded Date:
2019
HQ Location:
Colorado, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
9.6%
Web Visits Growth (Last 6 months):
53%
ZBiotics, based in San Francisco, is at the forefront of synthetic biology, creating genetically engineered probiotics to enhance health in innovative ways. Founded by scientists, the company's first product effectively tackles alcohol byproducts in the gut, leading a new wave of solutions for modern health challenges. ZBiotics stands out for its focus on using genetic engineering to improve bodily functions, reflecting a growing consumer trend towards proactive health and wellness management.
Founded Date:
2016
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
69%
Aptitude Medical Systems is on a mission to make health testing simple and accessible for everyone, everywhere. With backing from the Bill & Melinda Gates Foundation, they're pioneering easy-to-use diagnostic tests that can quickly identify health conditions, including STIs, right at home or in clinics. Their work, which builds on their success with an easy COVID-19 home test, aims to break down barriers to healthcare, especially in underserved areas.
Founded Date:
2011
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
31%
Web Visits Growth (Last 6 months):
301%
Loam Bio, founded in 2019 in New South Wales, is changing farming for the better by using special microbes to help crops grow stronger and healthier, while also helping the planet by storing more carbon in the soil. This innovative approach not only makes the soil better for future planting but also fights climate change.
Founded Date:
2019
HQ Location:
New South Wales, Australia
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
47%
Web Visits Growth (Last 6 months):
194%
Aspect Biosystems is revolutionising regenerative medicine with its innovative bioprinted tissue therapeutics, targeting challenging conditions like diabetes and obesity. By blending microfluidic 3D bioprinting technology with therapeutic cells, this Vancouver-based biotech company is creating treatments capable of repairing or replacing damaged organs.
Founded Date:
2013
HQ Location:
British Columbia, Canada
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
21%
Web Visits Growth (Last 6 months):
97%
Kriya Therapeutics, a California-based biotech innovator, is at the forefront of gene therapy, focusing on transformative treatments for metabolic, neurological, and eye diseases. Last year, the company significantly advanced its mission by securing over $430 million in Series C funding, contributing to a total of $600 million raised since its inception in 2019.
Founded Date:
2019
HQ Location:
California, United States
Total Funding Raised:
$
Company Size:
(
51-200
)
Employee Growth (Last 6 months):
1.1%
Web Visits Growth (Last 6 months):
218%
Generate Biomedicines, a trailblazer in Generative Biology, is transforming drug discovery with its machine learning-driven approach to designing and optimising protein-based medicines. Founded in 2018, the company has quickly risen to prominence, securing a groundbreaking $273 million in Series C funding last year, bringing its total financing to nearly $700 million.
Founded Date:
2018
HQ Location:
Pennsylvania, United States
Total Funding Raised:
$
Company Size:
(
201-500
)
Employee Growth (Last 6 months):
7%
Web Visits Growth (Last 6 months):
145%
Zymvol, based in Barcelona, is transforming the development of industrial enzymes through computer simulations. This innovative approach speeds up the creation of enzymes for use in pharmaceuticals, chemicals, and food industries, bypassing traditional lab methods for more efficient outcomes. Zymvol's cutting-edge technology is setting new standards in biotechnology, making significant strides globally.
Founded Date:
2017
HQ Location:
Catalonia, Spain
Total Funding Raised:
$
Company Size:
(
11-50
)
Employee Growth (Last 6 months):
19%
Web Visits Growth (Last 6 months):
70%
Published by
Specter redefines private market analysis with its unparalleled coverage of data points and growth metrics, ensuring users have access to the most comprehensive and up-to-date insights available. Our platform's strength lies in our proprietary classification and growth-ranking algorithms, which transform billions of data points into actionable intelligence. This enables our users to conduct in-depth analyses, benchmark companies accurately, and discover investment opportunities ahead of the competition. With a steadfast commitment to data accuracy and freshness, Specter is the go-to source for investors and analysts seeking a competitive edge.
Specter redefines private market analysis with its unparalleled coverage of data points and growth metrics, ensuring users have access to the most comprehensive and up-to-date insights available. Our platform's strength lies in our proprietary classification and growth-ranking algorithms, which transform billions of data points into actionable intelligence.
Related Posts
Related Posts
Related Posts
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
Products
Company
Specter provides real-time insights and emerging trends in the private markets. We equip investment firms and corporations with unparalleled, actionable intelligence on private companies.
©2024 Specter Labs OÜ. All rights reserved.